Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

funindasun,

No hanging around until the end.

Boing X 2

[jbog]

Goto wait till early December for LT gains to kick in. It's having a ucky day but after a 3600% gain I guess anything is expected.

[funindasun]

Boing! You leaving?

IRA... Thanks for pointing that out.

See you around Brah!

[funindasun]

Nice! when are you gonna sell?

[jbog]

Fun,

My Two Bit Lotto Ticket is still working. TRIL

[jbog]

So it's an tax annual filing you were referring too. thanks

[Boing x 2]

jbog,

Last post.

The trust has to pay capital gain taxes due to the sale of the stock.

It was not a stock swap. I would not have owed taxes with a stock swap.

The trust is not treated like an IRA where I will not pay taxes until I withdraw income.

My MNTA stock in the IRA will not get taxed and I will reinvest the proceeds.

The trust pays because it is in effect a sale of stock and I can't postpone paying the taxes even if I don't take money out of the trust.

Boing X 2

[jbog]

No pun or dig intended.

A buyout is one company offering cash to obtain another without any strings to current management. A merger is two companies combining with each companies current shareholders holding an equity stake. In a merger you receive stock and maybe a little true-up cash to settle the deal.

Now to the real question, why would an equity sale effect a trust, which was your original statement. Do you have to re-work your trust every time you buy or sell something?

[Boing x 2]

Jbog,


Does that make you feel better?

Merger, buyout whatever. You know damn well what I meant.

Just have to dig don't you.

Boing X 2

[jbog]

Didn't even think about that I will be required to file a trust return due to the merger.

What are you referring too by the word Merger?

[jbog]

my guess is its gone before turkey day

[funindasun]

Jbog, Boing...

Taxes is really weighing heavily on my mind.

Maybe start a new business- buy a commercial space, a couple of vehicles a truck and maybe a Porsche painted with my logo with a matching license plate (Surf 4 FUN!), a boat, a few surfboards etc. Take people surfing around the islands... Write it off?

I'm hoping it closes after December so that I'll have all next year to spring my plan. I don't know. I'm going pupule thinking about it.

[Boing x 2]

funindasun,

I am hoping this closes after Oct 1, due to tax consideration

Last quarter and I can pay the estimated taxes. Have my CPA giving me feedback tomorrow.

Didn't even think about that I will be required to file a trust return due to the merger.

Boing X 2

[jbog]

Unless the time could change your tax status it's time to move on.

Good Luck

[funindasun]

I will not sell nor tender my shares on the hopes MNTA have other bids.
They'll just get converted when it closes

March... I just held on tight...

But, whew! it is hard to watch gains vanish into thin air... I know of someone who capitulated that day and then bought back way higher on a FOMO...

From now, I'll give back some of my winnings by buying puts.
(they will likely expire worthless.)

hmmm... where to start?

[imnot6]

So you wouldn't sell before the tender, or wouldn't tender your shares and wait for the deal to close?

As for a meltdown, I'd even appreciate some dripping down the sides; who knew the March crashlette would be it in terms of buying opportunities?

[funindasun]

I will stick it out till...

The deal is done.
It provides insurance for a market meltdown.

I think it is coming.

I'll be looking to buy puts from here on.

[floblu14]

Suggestion - here's another bio I purchased with MNTA funds -

https://www.revance.com/ (check news, etc.)

May I say that Dew recommended such. Noble DEW - muchas gracias.

[floblu14]

THANK YOU, dear friends for your parting kind words.

Here's one of the bios that I have invested with MNTA funds:

28 August:

Enanta resumed with a Buy at Roth Capital. ENTA Roth Capital analyst Zegbeh Jallah resumed coverage of Enanta Pharmaceuticals with a Buy rating and $104 price target. The current stock price is largely reflective of the company's hepatitis C virus revenue stream and its cash position of $435M, thus leaving its clinical pipeline of potential blockbusters undervalued, Jallah tells investors in a research note. Enanta has a "very potent" hepatitis B virus core inhibitor, EDP-514, in Phase 2 studies with data expected in the first half of 2021, notes the analyst.

Read more at:
https://thefly.com/n.php?id=3152704

[funindasun]

Aloha Oe, Sir Floblu...

Take care.

[jbog]

Shorts took a 156,264,000 or more hit assuming none covered by the 19th

A mere pittance.

[Boing x 2]

Whoa,


Total shorts as of 08/14/2020
6801864

Shorts took a 156,264,000 or more hit assuming none covered by the 19th

Wonder if they are signing up with law firms. Would they have covered if they knew MNTA was in sale discussions.

I did say they must have had a death wish to be short with what was going on with the progress of the drugs.

Boing X 2

[Boing x 2]

Floblu14,


Good luck and safe travels.

Boing X 2

[imnot6]

Cheers, mate. Don't let anyone make off with your winnings - or get your goat ;^P

[jbog]

Flo,

Stay Well.

Enjoy

[floblu14]

Hello - goodbye

To all my good friends & fellow Momenta Alums. I have taken my MNTA $$Millions & with Elvis - left the building.

This A.M. I switched to 2 promising biotechs that I have been following recently. And, with encouragement from Dew, I have been re-born.

Bittersweet, but life goes on.

Stay well - success & happiness to all.

SIR FLO

[imnot6]

Ah, finally some accuracy as the analysts adjust the verniers on their retrospectoscopes. Gives the monkeys a chance to rest their throwing arms.

[floblu14]

Momenta initiated with a Market Perform at Raymond James 17:09 MNTA, JNJ Raymond James analyst Danielle Brill initiated coverage of Momenta (MNTA) with a Market Perform rating. The analyst notes that she had considered the company to be an "attractive" takeout candidate, but was surprised that Johnson & Johnson (JNJ) was the bidder. Brill adds that the deal will draw the attention of other Big Pharma companies to the FcRn class, though she expects no closing issues in the acquisition.

Read more at:
https://thefly.com/n.php?id=3150700

[funindasun]

Inside of me cries... for the things that could have been.

Especially now that convalescent plasma is officially approved to treat corona virus.

How far is it to connect this to M254?

Blood -> Plasma -> IVIG -> M254

Mind experiment tells me it's the natural progression.

MNTA holds a key to the death of this virus. M254 can work together along with the other treatments to stamp it out.

If Necuparanib is proven to be a potent agent against the virus, I'll be openly bawling...

Then, I don't know whether to see a psychiatrist, a financial adviser, or a lawyer...

[Boing x 2]

Former AG checking it out,


https://www.businesswire.com/news/home/20200820005628/en/

Boing X 2

[floblu14]

Here's another patent gift for J&J. Total is now 532 patents.

METHODS FOR PREDICTING RESPONSE TO TREATMENT..13 August

Abstract:
Described herein are methods for treating rheumatoid arthritis by determining whether a subject having rheumatoid arthritis will respond to an anti-TNF-alpha therapy based on the number of innate and adaptive immune cells in a sample from the subject prior to treatment.

BACKGROUND

[0002] Most patients initiating biologic therapy for rheumatoid arthritis are put on anti-TNF-alpha treatment as the first line treatment. However, approximately 30% of patients do not respond to anti-TNF-alpha treatment, and their disease often progresses before their non-response can be clinically determined. Although studies have been focused on understanding the biology underlying non-response in these patients, this remains an area of active investigation. As a result, new methods are needed for determining ahead of time whether a particular rheumatoid arthritis patient will respond to anti-TNF-alpha therapy, so that an effective drug that the patient is likely to respond to can be administered. This will help drive better treatment outcomes and reduce the burden on the healthcare system.

Read more:
https://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2020256851A1&KC=A1&FT=D&ND=3&date=20200813&DB=EPODOC&locale=en_EP

[jbog]

fUN,

Put the money in your pocket and be happy this fiasco is over. I'm happy the assets are in someones hands who can do something to finally help some patients.

Not matter which way you paint it, this company was once again distend to step on it's willy when the ship was coming in.

[funindasun]

Hmmm... Although I'd rather have the wedding annulled, I'll now take a white knight or a higher bid.

The other 'sort of' good thing about this is that J&J may have provided a backstop on the share price. An insurance 'sorta' speak.

[funindasun]

Jbog, Craig is a board member too.

But yeah we'll see.

[floblu14]

A white knight or a higher offer from J&J??

Published Friday, the 21st

Momenta call volume above normal and directionally bullish

12:45 MNTA Bullish option flow detected in Momenta with 3,745 calls trading, 1.9x expected, and implied vol increasing over 1 point to 8.06%. Dec-20 52.5 calls and Oct-20 52.5 calls are the most active options, with total volume in those strikes near 2,400 contracts. The Put/Call Ratio is 0.17. Earnings are expected on October 29th.

Read more at:
https://thefly.com/n.php?id=3150015

[jbog]

funinthesun.

We know nothing. We have to wait for the SEC filing and we'll learn how it unfolded.

This was a board decision.

[funindasun]

Like I said Craig should have stepped aside and have someone else lead Momenta.

Obviously he couldn't handle the pressure that this growing company put on him. He chose instead to take the easy out, and went for the first suitor that showed up at the front door. That way he would get the windfall.

I've read the letter to the employees.... but he failed to address us, the investors that stood by his side when the chips were down. Where was the CC? This is a big event.

He failed. I tend now to agree with jbog whose assessment was that this team likely isn't able to even handle a Burger King franchise.

[jbog]

Boing x 2

With Interest rates next to Zero no one in their sane ind would make a stock swap.

No such thing today.

[floblu14]

Gentlemen of the (open) BAR - FUN & BOING et al -

I, too, feel badly for Tony. If he had only announced his intentions prior, it would have been quite easy for us to dissuade him.

My financial management team's opinion is that Goldman Sachs main focus was on getting a fair price for all shareholders. (Personally, I tend to disagree in terms we've already stated.) Furthermore, they advised me to see how the dice falls in the next several weeks & not contact any of the ambulance chasers. You can be sure that they (class action suit attorneys) will contact us if the chips fall negatively or they ass u me they can "extort" multi-millions.

___________________________________________

Here's something quite interesting that was actually posted on the MNTA's IH page -

On August 19, 2020, Mr. Craig Wheeler, the Company’s Chief Executive Officer, provided the following electronic communication to its employees:


All,


Today we announced that Momenta has agreed to be acquired by Johnson & Johnson. I know this comes as a surprise to many of you. News like this brings with it many emotions. It will take some time for each of us to process. In this note I want to provide you with an overview of the facts to help you better understand what is ahead, as well as share some of my perspectives on the acquisition. We will also hold an employee all hands meeting this morning at 10:00 a.m. to provide more detailed information. Please bring your questions and we will explore them together. For contractors and co-ops, your manager will be reaching out to you soon with more information.


Acquisitions are a part of public company life and we often cannot control when or how they happen. J&J is a first-class company which shares our mission and key elements of our culture. Their offer recognizes the value we have created for patients and shareholders with the strong portfolio we have built and shepherded into development. J&J also recognizes the value of our team. They plan to keep Momenta’s presence in Cambridge and use it to build a greater J&J footprint in the Boston area. This is an important recognition of the value we have created for patients and the contributions our culture and team can bring to J&J.


J&J has been very thoughtful in how they are approaching Momenta’s integration into the J&J family of companies. At close, the company will remain intact, with all employees, including executive team members, asked to stay on to work with the J&J team. Together we will define how Momenta integrates into the J&J organization. They have also agreed to accelerate all outstanding stock and option grants for employees. This means that any annual grants you have outstanding, as well as the second tranche of performance shares you were expecting next year, will all be paid out to you when the deal closes. Ultimately, there will be some changes as the direction gets re-defined. The agreement also assures that if some ultimately do leave us, Momenta’s severance practice will be honored, and employee support services will be strong. J&J is clearly a people focused company, which is important as it has always been one of our key values.


In the coming weeks we will move from signing the deal to a final close. We expect this to take between one and four months, with closing expected before the end of the year. During this period between sign and close, Johnson & Johnson will commence a tender offer for all outstanding shares of Momenta stock, and we will jointly complete the filings necessary for regulatory approval. While that is all going on, we will continue to operate as an independent company.


This period between signing and closing of the deal will allow some time for J&J management to introduce themselves to Momenta. During these few weeks we will also work together to finalize plans for operations of Momenta immediately after the deal is closed. As per our agreement, we will seek input from J&J on certain decisions before the deal closes but will continue to run our business until the transaction is finalized. At closing we will formally become part of the J&J family. This process will start on Thursday, with a town hall style All Hands meeting where J&J leadership will introduce themselves to everyone, including a Q&A session to answer your questions.


I want to give you some perspectives on how to think about this acquisition. For a transition like this one, we will all need to process it in our own way. There is always a sense of loss and grieving that we must contend with. But it is also an opportune moment for rebirth as we work to shape the new destiny of our organization and ourselves. If we take advantage of this inflection point, each of us will grow in our own way and we may find opportunities we never knew existed.


As a part of J&J, our portfolio will be funded with resources far greater than we could muster on our own. I have gotten to know several of their executives. They are warm and compassionate people who truly have an interest in maintaining the spirit of Momenta as they work to integrate the company and take our programs forward. I am also convinced of the commitment their executives have to our vision for the company. They are fully committed to advancing nipocalimab in fetal maternal medicine: they are after all “the baby company”! Their global commercial reach and their mission to invest in rare disease medicine are a fantastic match for the broad portfolio we have begun to assemble. I believe that we can be much more together than we could achieve our own. As a part of J&J, our drug candidates will reach even more of the patients who desperately need them.


Approach this acquisition with a lens to all the opportunity this can create for Momenta and you, as we become a part of a great organization which also happens to be the largest and most successful health care company in the world.


Thank you all,

Craig


More important Q & A continues:

https://ih.advfn.com/stock-market/NASDAQ/momenta-pharmaceuticals-MNTA/stock-news/83104052/written-communication-by-the-subject-company-relat

[Boing x 2]

funindasun,

I agree. If they were going to put the company up for sale why not announce it to get the most and best bids.

For example Tony was unaware they were in talks to sell and he sells the day before the announcement. If he had been aware they were in talks would he have sold? He has a real gripe and loss.

I agree it looks like they tanked the stock and you are right why get a loan for 1 billion more if that wasn't the original price. This whole thing stinks.

It appears they were only looking out for their pockets and not the investor's. Where was the board on looking out for us? An idiot would know a cash sale would lessen the benefit to investors who were not invested in an IRA from a tax standpoint.

I have stock in our IRA and Trust so will get banged in our trust as a cash sale. Sure it is long term capital gains but, still a big chunk of money I have to fork out this year now vs. a stock swap and no current tax due. So that make a bunch of us take a hit.

I wish LLY or some else would come in and up the bid even if by a dollar and stock swap and I would vote for that.

Boing X 2

[funindasun]

Flo, Boing... There's something ain't right here.

They manipulated the stock price from ~$40 to ~$30 -the day of the announcement. This essentially wiped out ~ $1 Billion of the company's market cap. 1.There was no cause for the stock to go down. 2.There was a sudden increase and decrease of shorted shares.

We learn that J&J got a $7.5 Billion loan.
They bought Momenta for $6.5 Billion.
A difference of $1 Billion.

Was the original purchase price supposed to be $7.5 Billion? But because the stock price was manipulated down they paid only $6.5 Billion?

This looks very much like total manipulation. We need the SEC to look into this. They need to investigate the deal - the shorts, GS, J&J and Momenta management.

[floblu14]

How much is each patent worth?

INESTIMABLE value

This is the crux, the essence of any company's total worth.

[jbog]

With Momenta's history in the court system the answer would be zip.

I'm sure there's some value that J&J will find in them.

I don't know what the whining is about. $6.5B is a big and fair number. The real Problem is that it's spread over 123 million shares which is an additional 5 million more shares that will be given to the inside crooks.

[Boing x 2]

flovllu14,


Yep! Same here. I was laying in bed thinking about all the patents likewise.

How much is each patent worth?


Boing X 2

[floblu14]

Lest we forget -

I'm madder than the mad hatter!

CW - take it all - including the intellectual property - PATENT ESTATE.

Approximately 530 results found in the Worldwide database for:

Momenta Pharmaceuticals as the applicant.

https://worldwide.espacenet.com/searchResults?submitted=true&locale=en_EP&DB=EPODOC&ST=advanced&TI=&AB=&PN=&AP=&PR=&PD=&PA=momenta%20pharmaceuticals&IN=&CPC=&IC=

WTF - Is this worth ZERO?

[funindasun]

A break? $50 to $75 million?

Gotta be kidding me dude!

TSK! tsk! We've been had...

[jbog]

Craig did us a disservice.

Come-on man, Craig's walking away with $50 to $75 million, can't you give the poor guy a break.

Shame on you.

[funindasun]

Craig did us a disservice.

If I were to structure the deal...

I would have made sure that shareholders get compensated with future revenues of the current pipeline. If anything comes out of Necuparanib I would also make sure that at least half of that franchise profit goes to shareholders. This to me is fair. And then the price should have been $10 Billion. Then I would tell J&J to either Go BIG or go HOME!

Here's a double bird Craig! ONE in each hand!

I feel like suing you for Billion$!!!

Any lawyers out there who'll take my case? Cause clearly this the most egregious dereliction of duties I've ever seen!... imo

[funindasun]

I agree. Wait and see time..

Ok I'm with you guys, but with a little flair..

It's surf at sea time...

Surf's UP!

[Boing x 2]

floblu14,

I agree. Wait and see time.

Boing X 2